The Mechanism of Hypofibrinogenæmia in Premature Separation of the Normally Implanted Placenta

References

• Aas K. Proconvertin og konvertin. Thesis. Oslo Akad. Trykningscentral. 1952; 90
   Google Scholar
• Alagille D., Soulier J. P. Action des enzymes protécolytiques sur le sang total ‘in vitro’. Modifications des facteurs de coagulation et du complément. Sem. Hop. Paris 1956; 32: 355–359
   Google Scholar
• Albrechtsen O. K., Storm O., Trolle D. Afibrinogenæmi i tilslutning til for tidlig placentaløsning. Ugeskr. Læg. 1955; 117: 1566–1569
   Google Scholar
• Alexander B., Meyers L., Kenny J., Goldstein R., Gurevich V., Grinspoon L. Elevated SPCA (Convertin) complex in pregnancy. Its possible role in pathogenesis of thromboembolism. J. clin. Invest. 1954; 33: 914–915
   Google Scholar
• Alexander B., Meyers L., Kenny J., Goldstein R., Gurevich V., Grinspoon L. Blood coagulation in pregnancy. Proconvertin and prothrombin and the hypercoagulable state. New Engl. J. Med. 1956; 254: 358–363
   PubMed Web of Science ®Google Scholar
• Ashworth C. T., Stouffer J. G. A study of fibrin deposition in the placenta. Amer. J. clin. Path. 1956; 26: 1031–1043
   Google Scholar
• Astrup T., Volkert M. On the action of thrombin and thrombokinase in vivo. Acta med. scand. 1943; 115: 393–400
   Google Scholar
• Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 1952; 40: 346–351
   PubMed Web of Science ®Google Scholar
• Astrup T., Sterndorff I. An activator of plasminogen in normal urine. Proc. Soc. exp. Biol. (N. Y.) 1952; 81: 675–678
   PubMed Web of Science ®Google Scholar
• Attwood H. D., Park W. W. Embolism to the lungs by trophoblast. J. Obstet. Gynaec. Brit. Comm. 1961; 68: 611–617
   PubMedGoogle Scholar
• Barcroft J., Herkel W., Hill S. The rate of blood flow and gaseous metabolism of the uterus during pregnancy. J. Physiol. (Lond.) 1933; 77: 194–206
   Google Scholar
• Bardawil W. A., Toy B. L. The natural history of choriocarcinoma: Problems of immunity and spontaneous regression. Ann. N. Y. Acad. Sci. 1959; 80: 197–261
   Google Scholar
• Beller F. K., Glas P. Inhibition of clotting as the result of plasminogen activition by streptokinase. II. Analytical studies of the clotting mechanism. Thrombos. Diathes. haemorrh. (Stuttg.) 1960; 4: 520–532
   Google Scholar
• Beller F. K., Nagel W. Thrombolyse: Eine neue Therapie thromboembolischer Erkrankungen. Med. Welt (Stuttg.) 1960, Nr. 36 u. 37
   Google Scholar
• Biezenski J. J. Antifibrinolytic activity in normal pregnancy. J. clin. Path. 1960; 13: 220–223
   PubMed Web of Science ®Google Scholar
• Biezenski J. J., Moore H. C. Fibrinolysis in normal pregnancy. J. clin. Path. 1958; 11: 306–310
   PubMed Web of Science ®Google Scholar
• Biezenski J. J., Moore H. C. Fibrinolysis following accidental hæmorrhage. J. Obstet. Gynaec. Brit. Emp. 1959; 66: 82–85
   Google Scholar
• Blombäck B., Blombäck M. Purification of human and bovine fibrinogen. Ark. Kemi 1956; 10: 415–443
   Google Scholar
• Borchgrevink C. F., Pool J. G., Stormorken H. A. A new assay for factor V (proaccelerin-accelerin), using Russell's viper venom. J. Lab. clin. Med. 1960; 55: 625–632
   PubMedGoogle Scholar
• Brecher G., Schneiderman M., Cronkite E. P. The reproducibility and constancy of the platelet count. Amer. J. clin. Path. 1953; 23: 15–26
   PubMed Web of Science ®Google Scholar
• Caton W. L., Roby Ch. C., Reid D. E., Gibson J. G. Plasma volume and extravascular fluid volume during pregnancy and the puerperium. Amer. J. Obstet. Gynec. 1949; 57: 471–481
   Google Scholar
• Christensen L. K. The turnover of plasma fibrinogen. Acta med. scand. 1958; 162: 407–414
   Google Scholar
• Dam H., Larsen H., Plum P. Om fibrinopeni ved for tidlig løsning av placenta. Ugeskr. Læg. 1941; 103: 257–263
   Google Scholar
• de Lee J. B. Principle and Practice of Obstetrics. 5th. Ed. W. B. Saunders Comp, Philadelphia and London 1930; 408
   Google Scholar
• Dieckmann W. J. Blood chemistry and renal function in abruptio placentae. Amer. J. Obstet. Gynec. 1936; 31: 734–745
   Google Scholar
• Dieckmann W. J. The toxemias of pregnancy. The C. V. Mosby Comp., St Louis 1952
   Google Scholar
• Dieckmann W. J., Wegner C. R. Studies of the blood in normal pregnancy. IV. Percentages and grams per kilogram of serum proteins and fibrin and variation in total amounts of each. Arch, intern. Med. 1934; 53: 353–366
   Google Scholar
• Dold H. Ueber die Giftigkeit von wässerigen Organextrakten und die entgiftende Wirkung frischen Serums. Z. Immun.-Forsch. 1911a; 10: 53–67
   Google Scholar
• Dold H. Weitere Untersuchungen über die wässerigen Organextraktgifte und die entgiftende Wirkung frischen Serums. Dtsch. med. Wschr. 1911b; 37: 1644–1647
   Google Scholar
• Dold H., Ogata S. Weitere Studien über die wässerigen Organextraktgifte. Z. Immun.-Forsch. 1912; 13: 667–688
   Google Scholar
• Feeney J. K. Accidental hæmorrhage. Irish. J. med. Sci. 1955; 195–214, May.
   Google Scholar
• FitzGerald T. B., Jackson S. H. Afibrinogenæemia in obstetrics. Lancet 1956; I: 412–414
   Google Scholar
• Foster J. B. T., DeNatale A., Dotti L. B. Determination of plasma fibrinogen by means of centrifugation after heating. Amer. J. clin. Path. 1959; 31: 42–45
   Google Scholar
• Fowell A. H. Turbidimetric method of fibrinogen assay. Amer. J. clin. Path. 1955; 25: 340–342
   PubMedGoogle Scholar
• Fresh J. W., Ferguson J. H., Lewis J. H. Blood clotting studies in parturient women and the newborn. Obstet. Gynec. 1956; 7: 117–127
   Google Scholar
• Fresh J. W., Adams H., Morgan F. M. Vitamin K - Blood clotting studies during pregnancy, and prothrombin and proconvertin levels in the newborn. Obstet. Gynec. 1959; 13: 37–40
   Google Scholar
• Fretheim B. Carcinoma ventriculi behandlet med abdominothoracal total gastrectomi. Akademisk Trykningscentral-Blindern. Oslo. Thesis. 1953; 155
   Google Scholar
• Fretheim B. The total circulating serum protein in patients with gastric carcinoma. Acta chir. scand. 1954; 108: 125–134
   Google Scholar
• Fulton L. D., Page E. W. Nature of the refractory state following sublethal dose of human placental thromboplastin. Proc. Soc. exp. Biol. (N. Y.) 1948; 68: 594–596
   Google Scholar
• Glas P., Beller F. K. Inhibition of clotting as the result of plasminogen activation by streptokinase. I. Studies of the inactivation of fibrinogen. Thrombos. Diathes. haemorrh. (Stuttg.) 1960; 4: 507–519
   Google Scholar
• Godal H. C. Simple syneresis procedure for fibrinogen assay. Scand. J. clin. Lab. Invest. 1961; 13: 530
   PubMed Web of Science ®Google Scholar
• Goossens N., Walcher A. Ueber den thromboembolie-verhütenden Effekt sublethaler i. v. Thromboplastindosen. Z. ges. exp. Med. 1957; 129: 171–180
   Google Scholar
• Hammond J. D. S., Verel D. Observation on the distribution and biological half-life of human fibrinogen. Brit. J. Haemat. 1959; 5: 431–438
   Google Scholar
• Hartmann R. C., Conley C. L., Krevans J. R. The effect of intravenous infusion of thromboplastin on ‘heparin tolerance’. J. clin. Invest. 1951; 30: 948–956
   Google Scholar
• Hatton R. L. Coagulation defects in patients with abruptio placentae. Amer. J. Obstet. Gynec. 1961; 82: 177–181
   Google Scholar
• Hayahsi T. Ueber die Entgiftungsfähigkeit des Serums gegen das Placentargift. Arch. Gynäk. 1923a; 119: 29–56
   Google Scholar
• Hayahsi T. Ueber die Entgiftungfähigkeit des Serums gegen das Placentargift. Arch. Gynäk. 1923b; 119: 505–551
   Google Scholar
• Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. clin. Lab. Invest. 1957; 9: 183, suppl. 27. Thesis
   Google Scholar
• Hjort P. F., Rapaport S. T., Owren P. A. A simple, specific, one stage prothrombin assay, using Russell's viper venom in cephalin suspension. J. Lab. clin. Med. 1955; 46: 89–97
   PubMed Web of Science ®Google Scholar
• Hodgkinson C. P., Margulis R. R., Luzadre J. H. Etiology and management of hypofibrinogenemia of pregnancy. J. Amer. med. Ass. 1954; 1: 557–561
   Google Scholar
• Howard B. K., Goodson J. H. Experimental placental abruption. Obstet. Gynec. 1953; 2: 442–446
   Google Scholar
• Howard B. K., Goodson J. H., Mengert W. F. Supine hypotensive syndrome in late pregnancy. Obstet. Gynec. 1953; 1: 371–377
   PubMed Web of Science ®Google Scholar
• Ikle A. Trophoblastzellen in strömenden Blut. Schweiz. med. Wschr. 1961; 91: 943–945
   Google Scholar
• Ingram G. I. C., Pinniger J. L., Vallet L. Survival in an afibrinogenæmic subject of fibrinogen prepared from ‘time-expired’ blood. Lancet 1960a; 1: 135–137
   Google Scholar
• Ingram G. I. C., Norris P. R., Tanner E. I. Acute coagulation disorders at parturition. J. Obstet. Gynæc. Brit. Emp. 1960b; 67: 367–383
   Google Scholar
• Jackson D. P., Hartmann R. C., Busby T. Fibrinogenopenia complicating pregnancy. Obstet. Gynec. 1955; 5: 223–247
   PubMed Web of Science ®Google Scholar
• Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Scand. J. clin. Lab. Invest. 1955; 7: 102, suppl. 14
   Google Scholar
• Javert C. T., Moore R. A. Prothrombin concentration in parturient women and their newborn infants. Amer. J. Obstet. Gynec. 1940; 40: 1022–1025
   Google Scholar
• Jeffcoate T. N. A., Scott J. S. Hypofibrinogenæmia in obstetrics. J. Obstet. Gynaec, India. 1956; 6(3)12, March
   Google Scholar
• Jennison R. F., Walker A. H. C. Foetal death in utero with hypofibrinogenæmia. Managed conservatively. Lancet 1956; 11: 607–609
   Google Scholar
• Johnson J. F., Seegers W. H., Braden R. G. Plasma ac-globulin changes in placenta abruptio. Amer. J. clin. Path. 1952; 22: 322–326
   Google Scholar
• Johnston Ch. L., Jr., Ferguson J. H., O'Hanlon F. A., Black W. L. The fate of factor VII and Stuart factor during the clotting of normal blood. Thrombos. Diathes. haemorrh. (Stuttg.) 1959; 3: 367–374
   Google Scholar
• Kaeser O. Ueber Blutgerinnungsstörungen bei Fällen von schweren vorzeitigen Lösung der Plazenta. Geburtsh. u. Frauenheilk. 1952; 12: 10–18
   Google Scholar
• Kaeser O. Fibrinolyse dans certains cas de décollement prémature du placenta. Rev. Hémat. 1952; 7: 55–59
   Google Scholar
• Kellog F. S. Hemorrhagic tendencies in toxemia of pregnancy (practical evaluation and management). Obstet. Gynec. Surv. 1948; 3: 746–757
   Google Scholar
• Kennan A. L., Bell W. N. Blood coagulation during normal pregnancy, labor and the puerperium. Amer. J. Obstet. Gynec. 1957; 73: 57–64
   Google Scholar
• Koller F., Held F. Der Prothrombin und Faktor VII-Gehalt des Blutes am Ende der Schwangerchaft und beim Neugeborenen. Gynaecologia (Basel) 1952; 134: 43–46
   Google Scholar
• Lassen M. Heat denaturation of plasminogen in fibrin plate method. Acta. physiol. scand. 1952; 27: 371–376
   Google Scholar
• Lewis J. H., Howe A. C., Ferguson J. H. Thrombin formation II. Effects of lysin (fibrinolysin, plasmin) on prothrombin, ac.-globulin and tissue thromboplastin. J. clin. Invest. 1949; 28: 1507–1510
   Google Scholar
• Lewis J. H., Leary D. C., Fresh J. W., Ferguson J. H. Fibrinolytic fibrinogenopenia. Amer. J. Obstet. Gynec. 1958; 75: 418–422
   Google Scholar
• Lewis J. H., Ferguson E. E., Schoenfeld C. Studies concerning the turnover of fibrinogen I131 in the dog. J. Lab. clin. Med. 1961; 58: 247–258
   Google Scholar
• Loeliger A., Koller F. Behaviour of factor VII and prothrombin in late pregnancy and the newborn. Acta haemat. (Basel) 1952; 7: 157–161
   PubMed Web of Science ®Google Scholar
• Lövset J., Knutsen K., Jacobsen Aa. Treatment with anticoagulants of pregnant women with previous severe toxæmia. Acta obstet. gynec. scand. 1957; 36: 492–498
   Google Scholar
• Macfarlane R., Biggs R. Observations on fibrinolysis: spontaneous activity associated with surgical operations, trauma etc. Lancet 1946; 11: 862–864
   Google Scholar
• Margulis R. R., Luzadre J. H., Hodgkinson C. P. Fibrinolysis in labor and delivery. Obstet. Gynec. 1954; 3: 487–490
   Google Scholar
• Mellanby J. The coagulation of blood. Part II. The actions of snake venoms, peptone, and leech extract. J. Physiol. (Lond.) 1909; 38: 441–503
   Google Scholar
• Mengert W. F., Goodson J. H., Campbell R. G., Haynes D. M. Observations on the pathogenesis of premature separation of the normally implanted placenta. Amer. J. Obstet. Gynec. 1953; 66: 1104–1112
   Google Scholar
• Mills C. A. The action of tissue extracts in the coagulation of blood. J. biol. Chem. 1921; 46: 167–192
   Google Scholar
• Moloney W. C., Egan W. J., Gorman A. J. Acquired afibrinogenemia in pregnancy. New Engl. J. Med. 1949; 240: 596–598
   Google Scholar
• Mor A., Yang W., Schwarz A., Jones W. C. Platelet counts in pregnancy and labor. Obstet. Gynec. 1960; 16: 338–343
   Google Scholar
• Morse A. H. Premature separation of the normally implanted placenta. Surg. Gynec. Obstet. 1918; 26: 133–138
   Google Scholar
• de Nicola P. Factor VII (SPCA). Its physiopathologic significance. Blood 1953; 8: 947–954
   Google Scholar
• Niesert H. W. Das Verhalten der Fibrinolyse unter der Geburt und post partum. Arch. Gynäk. 1955; 187: 144–153
   Google Scholar
• Nilsen P. A. Premature separation of the normally implanted placenta. Acta obstet. gynec. scand. 1958; 37: 195–260
   Google Scholar
• Norris R. F., Rush A. A comparison of the prothrombin levels of maternal and cord blood at delivery. Surg. Gynec. Obstet. 1940; 70: 1006–1010
   Google Scholar
• Obata I. Die Entgiftung des Placentagiftes durch Serum. Arch. Gynäk. 1923a; 118: 586–624
   Google Scholar
• Obata I. Beitrage über das Wesen der Eklampsic. Arch. Gynäk. 1923b; 119: 69–79
   Google Scholar
• Owren P. A. The coagulation of blood. Investigations on a new clotting factor. Acta med. scand. 1947; 128: 327, suppl. 194. Thesis.
   Google Scholar
• Page E. W. In Kellog 1948, discussion
   Google Scholar
• Page E. W., Fulton L. D., Glendening M. B. The cause of the blood coagulation defect following abruptio placentae. Amer. J. Obstet. Gynec. 1951; 61: 1116–1122
   Google Scholar
• Page E. W., Glendening M. B., Strei L., Scott K. G. The fate of intravenously injected placental extracts. Amer. J. Obstet. Gynec. 1953; 65: 789–795
   Google Scholar
• Parfentjev I. A., Johnson M. L., Cliffton E. E. The determination of plasma fibrinogen by turbidity with ammonium sulphate. Arch. Biochem. 1953; 46: 470–480
   PubMed Web of Science ®Google Scholar
• Pechet L. Elevated factors VII and X in pregnancy, a ‘hyper-coagulable’ state. J. clin. Invest. 1960; 39: 1015
   Google Scholar
• Pechet L., Alexander B. Increased clotting factors in pregnancy. New Engl. J. Med. 1961; 265: 1093–1097
   PubMed Web of Science ®Google Scholar
• Phillips L. L. Etiology of afibrinogenemia: fibrinogenolytic and fibrinolytic phenomena. Ann. N. Y. Acad. Sci. 1959; 75: 676–684
   Google Scholar
• Phillips L. L., Montgomery G., Jr., Taylor H. C. The role of the fibrinolytic enzyme system in obstetrical afibrinogenemia. Amer. J. Obstet. Gynec. 1957; 73: 43–56
   Google Scholar
• Phillips L. L., Skrodelis V. The fibrinolytic enzyme system in normal, hemorrhagic and disease states. J. clin. Invest. 1958; 37: 965–973
   Google Scholar
• Plass E. D., Matthew C. W. Plasma protein fractions in pregnancy, labor and puerperium. Amer. J. Obstet. Gynec. 1926; 12: 346–358
   Google Scholar
• Pritchard J. A. Abruptio placentae and hypofibrinogenemia. Amer. J. Obstet. Gynec. 1958; 76: 347–362
   Google Scholar
• Pritchard J. A., Wright M. R. Pathogenesis of hypofibrinogenemia in placental abruption. New Engl. J. Med. 1959; 261: 218–222
   PubMed Web of Science ®Google Scholar
• Ratnoff O. D., Conley C. L. Studies on afibrinogenemia II. The defibrinating effect on dog blood of intravenous injection of thromboplastic Material. Bull. Johns Hopk. Hosp. 1951; 88: 414–424
   Google Scholar
• Ratnoff O. D., Colopy J. E., Pritchard J. A. The blood clotting mechanism during normal parturition. J. Lab. clin. Med. 1954; 44: 408–415
   PubMedGoogle Scholar
• Ratnoff O. D., Holland Th. R. Coagulation components in normal and abnormal pregnancies. Ann. N. Y. Acad. Sci. 1959; 75: 626–633
   Google Scholar
• Ratnoff O. D., Pritchard J. A., Colopy J. E. Hemorrhagic states during pregnancy. New Engl. J. Med. 1955; 253: 63–69, 97–102
   PubMed Web of Science ®Google Scholar
• Sawitsky A., Plotkin D. Hypofibrinogenemia and postpartum hemorrhage. N. Y. St. J. Med. 1955; 55: 1153–1158
   Google Scholar
• Schneider C. L. The active principle of placental toxin: thromboplastin; its inactivator in blood: antithromboplastin. Amer. J. Physiol. 1947; 149: 123–129
   Google Scholar
• Schneider C. L. Thromboplastin complications of late pregnancy. Toxæmias of Pregnancy, human and veterinary. A Ciba Foundation Symposium. J. & A. Churchill Ltd., London 1950a; 163–181
   Google Scholar
• Schneider C. L. Complications of late pregnancy in rabbits induced by experimental trauma. Surg. Gynec. Obstet. 1950b; 90: 613–622
   Google Scholar
• Schneider C. L. ‘Fibrin embolism’ (disseminated intravascular coagulation) with defibrination as one of the end results during placental abruptio. Surg. Gynec. Obstet. 1951a; 92: 27–34
   PubMedGoogle Scholar
• Schneider C. L. Thromboplastin complications of pregnancy. Bull M. Hague matern. Hosp. 1951b; 4: 2–15
   Google Scholar
• Schneider C. L. Fibrin embolism (disseminated intravascular coagulation) and the aetiology of eclampsia. J. Obstet. Gynaec. Brit. Emp. 1951c; 58: 538–554
   Google Scholar
• Schneider C. L. Rupture of the basal plate in abruptio placentae: a pathway of autoextraction from the decidua into the maternal circulation. Amer. J. Obstet. Gynec. 1952; 63: 1078–1090
   Google Scholar
• Schneider C. L., Engstrom R. M., Schneider C. L. Experimental pulmonary arterial occlusion: acute cor pulmonale simulating ‘obstetric shock’ of late pregnancy. Amer. J. Obstet. Gynec. 1954; 68: 691–705
   PubMed Web of Science ®Google Scholar
• Schneider C. L. Coagulation defects in obstetric shock: meconium embolism and heparin; fibrin embolism and defibrination. Amer. J. Obstet. Gynec. 1955; 69: 758–775
   PubMed Web of Science ®Google Scholar
• Schneider C. L. Mechanisms of production of acute fibrinogen deficiencies. Progr. Hemat. 1956; 1: 202–220
   PubMedGoogle Scholar
• Schneider C. L. Fibrination and defibrination. Physiologie und Pathologie der Blutgerinnung in der Gestationsperiode. Internationales Symposion, H. Runge, I. Hartert. Friedrich-Karl Schattauer-Verlag, Stuttgart 1957
   Google Scholar
• Sharp A. A., Howie B., Biggs R., Methuen D. T. Defibrination syndrome in pregnancy. Value of various diagnostic tests. Lancet 1958; 11: 1309–1313
   Google Scholar
• Shea S. M. Fibrinolysis in the puerperium. Irish J. med. Sci. 1955; 233–237, May.
   Google Scholar
• Sheehan H. L. The pathology of shock in obstetrics. Rotunda Hospital Bicentenary 151–163. The Parkside Press Limited, Dublin 1947
   Google Scholar
• Skajaa K. Variations in the cell volume of the blood. Acta obstet. gynec. scand. 1929; 8: 370–430
   Google Scholar
• Smith O. W. Menstrual toxin. Amer. J. Obstet. Gynec. 1947; 54: 201–211
   Google Scholar
• Soulier J. P., Alagille D., Larrieu M. J. Modifications ‘in vivo’ des facteurs de coagulation dans les fibrinolyses. Valeur du déficit en proaccélérine pour le diagnostic des protéolyses frustes ou latentes. Sem. Hôp. Paris 1956; 32: 359–366
   Google Scholar
• Stefanini M., Turpini A. Fibrinogenopenic accident of pregnancy and delivery: a syndrome with multiple etiological mechanisms. Ann. N. Y. Acad. Sci. 1959; 75: 601–625
   PubMed Web of Science ®Google Scholar
• Strumia M. M., Sample A. B., Hart E. D. An improved micro hematocrit method. Amer. J. clin. Path. 1954; 24: 1016–1024
   PubMed Web of Science ®Google Scholar
• Thomson K. J., Hirsheimer A., Gibson J. G., Evans W. A., Jr. Studies on the circulation in pregnancy. Blood volume changes in normal pregnant women. Amer. J. Obstet. Gynec. 1938; 36: 48–59
   Google Scholar
• Thordarson P. Hyperprothrombinæmia during pregnancy. Nature (Lond.) 1940; 145: 305
   Google Scholar
• Vara P., Kotsalo K. Ueber die Schwankungen des Fibrinogengehalts während der Geburt bei gesunden und toxämischen Frauen. Ann. Chir. Gynaec. Fenn. 1958; 47: 207–225
   Google Scholar
• Waaler B. A. Contact activation in the intrinsic blood clotting system. Oslo University Press. Thesis. 1959; 133
   Google Scholar
• Weiner A. E., Reid D. E., Roby Ch. C. Coagulation defects associated with premature separation of the normally implanted placenta. Amer. J. Obstet. Gynec. 1950; 60: 379–386
   Google Scholar
• Weiner A. E., Reid D. E., Roby Ch. C. Incoagulable blood in severe premature separation of the placenta: A method of management. Amer. J. Obstet. Gynec. 1953; 66: 475–499
   Google Scholar
• Welsh J. F. Serum transfusion in the treatment of deficiency of plasma thromboplastin component. Amer. J. clin. Path. 1960; 33: 118–123
   Google Scholar
• Wessler S., Ward K., Ho C. Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J. clin. Invest. 1955; 34: 647–651
   Google Scholar
• Wessler S., Morris L. E. Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis. Circulation 1955; 12: 553–556
   Google Scholar
• Wessler S., Ballon J. D., Katz J. H. Studies in intravascular coagulation. New Engl. J. Med. 1957; 256: 1223–1225
   Google Scholar
• Wessler S., Reimer S. M. The role of human coagulation factors in seruminduced thrombosis. J. clin. Invest. 1960; 39: 262–265
   Google Scholar
• Willson J. R., Munnel E. R. Fibrinolytic activity in blood serum during pregnancy complicated by hypertensive toxemias. Proc. Soc. exp. Biol. (N. Y.) 1946; 62: 277–279
   PubMed Web of Science ®Google Scholar
• Wintrobe M. M. Clinical Hematology. Fourth Edition. Lea & Febiger, Philadelphia 1956
   Google Scholar
• Wooldridge L. C. Ueber intravasculäre Gerinnungen. Arch. Anat. Physiol 1886; 397–399
   Google Scholar